Latest in Here's why Eli Lilly bounced back, plus mega caps lag while staples stocks rise
Sort by
3,546 items
-
Here's why Eli Lilly bounced back, plus mega-caps lag while staples stocks rise
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.Business - CNBC - 7 hours ago -
Cramer says 'so many things are working' in the market. Here are a few bright spots
The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.Business - CNBC - 10 hours ago -
S&P 500 eyes another record close — plus, our 2 health-care stocks that defied the group
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.Business - CNBC - October 18 -
Lilly’s Mounjaro, Zepbound drugs see strong demand. So why did sales disappoint?
Eli Lilly’s stock heads for biggest selloff in more than three years after sales of anti-obesity drugs Mounjaro and Zepbound came up well short of forecasts.Business - MarketWatch - October 30 -
Eli Lilly's quarter was messy. What to do with the stock is more clear-cut
We're upgrading our rating on the drugmaker to a buy-equivalent 1.Business - CNBC - October 30 -
Eli Lilly's Zepbound and Mounjaro are no longer in shortage. Here's where their sales still disappointed
Eli Lilly blamed the misses on drug wholesalers cutting inventory of Zepbound and Mounjaro.Business - CNBC - October 30 -
Eli Lilly stock tumbles after drug giant misses estimates and slashes profit guidance
Skyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase manufacturing capacity.Business - CNBC - October 30 -
One of our stocks is holding back the Dow as the S&P 500 and Nasdaq bounce back
The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.Business - CNBC - October 24 -
It's brutal out here: Olivia Rodrigo bounces back after falling through an open trap door
It seems Olivia Rodrigo took too many steps forward and no steps back — and fell through a trap door in the stage during a recent concert. 'I'm OK,' she says.Entertainment - Los Angeles Times - October 15 -
Apple sells $46 billion worth of iPhones over the summer as AI helps end slump
Apple snapped out of a recent iPhone sales slump during its summertime quarterTech - ABC News - October 31 -
Eli Lilly to trial use of weight loss drugs to combat unemployment in UK
U.S. pharmaceutical giant Eli Lilly is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with the U.K.Business - CNBC - October 15 -
Eli Lilly to trial use of weight loss drugs to combat unemployment in U.K.
U.S. pharmaceutical giant Eli Lilly is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with the U.K.Top stories - NBC News - October 16 -
Shares in weight-loss drugmaker Eli Lilly fall on disappointing sales
US group revises down upper end of full-year revenue estimatesBusiness - Financial Times - October 30 -
Why bond yields are rising and what stock investors should do about that
Bond traders are at it again, pushing Treasury yields higher and signaling the Fed was too heavy-handed when it cut rates last month.Business - CNBC - October 23 -
Fed rate cuts were supposed to buoy small-cap stocks. What’s holding them back?
Small-cap stocks were widely expected to benefit most from the Federal Reserve’s interest-rate cuts — but that has yet to materialize.Business - MarketWatch - October 26 -
Trump's DJT stock is surging, lifting Truth Social. Here's why.
Shares of Trump Media & Technology Group, which trades under the DJT ticker, jumped 18% on Monday. Here's why.Top stories - CBS News - October 14 -
Vistra’s stock has quadrupled in a year. Here’s why it’s not too late to buy.
Vistra’s stock is J.P. Morgan’s top pick among independent power producers, even though its shares have already rocketed more than fourfold over the past 12 months.Business - MarketWatch - October 18 -
Apple’s stock gets rare bearish call — and here are the four reasons why
KeyBanc worries about low upgrade rates and the potential for a lower-cost iPhone SE to cannibalize sales of more expensive models, for example.Business - MarketWatch - October 25 -
U.S. stocks could face scariest week yet of 2024. Here’s why.
The U.S. stock market’s record-setting rally could face its scariest stretch of 2024 in the week ahead, with a dizzying array of risks on the docket.Business - MarketWatch - October 28 -
Stocks are expensive, but their rally can continue for at least another year. Here’s why.
Stocks’ stellar run over the past 18 months has given investors plenty of reasons to celebrate. But it has also saddled them with some of the most expensive valuations in recent memory.Business - MarketWatch - October 29 -
PayPal beat big on a profit metric, but here’s why its stock is falling
PayPal’s fourth-quarter revenue view came in below expectations. The company said it’s focusing on “profitable growth.”Business - MarketWatch - October 29 -
Intel books big charges for restructuring, but here’s why its stock is surging
The company says business trends are improving despite ‘noisy’ earnings.Business - MarketWatch - November 1 -
Upstart’s stock roars higher. Here’s why analysts say the tide is turning.
Analysts say the AI lender is on a better track is it benefits from an improved interest-rate climate, funding partnerships and “solid” credit trends.Business - MarketWatch - 11 hours ago -
Why a stock picking approach to small caps may boost performance right now
Rob Harvey, who's behind the Dimensional U.S. Small Cap ETF, uses an actively managed approach to buying the group.Business - CNBC - October 19 -
Here’s why some NBA teams show their games on TV for free, while others charge fans hundreds of dollars
NBA owners have very different ideas about the benefits of showing their teams’ games for free.Business - MarketWatch - November 1 -
McCarthy: Cowboys 'relish' chance to bounce back
Cowboys coach Mike McCarthy said he and his team "relish" the opportunity to bounce back from one of the worst losses at home in franchise history.Sports - ESPN - October 14 -
Sark: Ewers bounce-back showed 'true character'
Quinn Ewers settled into the kind of rhythm his Texas coaches and teammates are accustomed to Saturday night in a hard-fought 27-24 win over Vanderbilt.Sports - ESPN - October 27 -
Jim Cramer identifies an interesting buy level for our worst performing Big Tech stock this year
The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.Business - CNBC - October 31 -
Why U.S. stock market’s slump on rising Treasury yields may be short-lived
The U.S. stock market appears to be taking a breather from setting fresh highs as interest rates in the bond market climb, leaving the S&P 500 sharply lower Wednesday.Business - MarketWatch - October 23 -
What the Trump win means for the mega-cap tech giants, according to this high-profile analyst
Shifts in the White House attitude to AI, regulation and electric vehicles may have a big impact on big tech.Business - MarketWatch - 2 days ago -
Jews shut down the New York Stock Exchange to protest Israel. Here’s why | Elena Stein
As the descendant of a survivor of a genocide, the Holocaust, I refuse to be a bystander to another genocide. Time after time, Sha’ban al-Dalou, a 19-year-old software engineering student living in ...World - The Guardian - October 18 -
Here's why Goldman Sachs' gloomy 10-year stock market forecast is no reason panic
The research emphasizes the importance of the kind of stock picking we do.Business - CNBC - October 22 -
‘DJT’ is booming. Here’s why other SPAC stocks haven’t been so lucky.
A surge of companies decided to go public via SPAC mergers in 2020 and 2021. Since then, not so much.Business - MarketWatch - October 24 -
Stock-market investors have ‘no clear playbook’ for Harris election win. Here’s why.
A victory by Vice President Kamala Harris over Donald Trump next week might leave investors temporarily lost, says a closely followed Wall Street research analyst.Business - MarketWatch - October 29